Alert Patients About Changes to Their Tramadol Rxs

August 2014

Tramadol (Ultram, Ultracet, etc) will be a Schedule IV controlled substance at the federal level starting August 18, 2014.

This isn't a big surprise. Tramadol is a weak opioid...with a similar potential for abuse as propoxyphene.

In fact, tramadol is already controlled in some states...including New York, Massachusetts, Georgia, and Illinois.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Infectious Diseases Watch For NEW Antibiotics for Skin Infections
Measles Identify Patients Who Could Benefit From Measles Vaccination
Diabetes Consider a GLP-1 Agonist for Diabetic Patients on 2 or 3 Oral Meds
Pediatrics Consider Adding Special Notes on Kids' Quinolone Rxs
Benzodiazepines Help Patients Taper Off Benzodiazepines
Neurology & Pain Test Patients With Memory Loss
Sleep Disorders Avoid Sedatives With Sleep Apnea
Fungal Infections Suggest Topical Jublia for Patients Who Can't Use Oral Terbinafine
Infectious Diseases Help Avoid Serious Interactions With Long-Term Antibiotics
Opioids Alert Patients About Changes to Their Tramadol Rxs
Diabetes Use Pioglitazone for Most Patients...if a Glitazone is Needed
Cardiology Don't Use the New Oral Antiplatelet Drug Zontivity Alone
Antiepileptics Watch for Three New Antiepileptics
Practice Caution Patients About Flammable Meds